[
{
“ProductName”: “IVAHART”,
“RegularizationNumber”: “105250090”,
“RegularizationDate”: “07/06/2021”,
“CNPJ”: “33.078.528/0001-32”,
“CaseNumber”: “25351.679486/2018-91”,
“RegularizationDueDate”: “06/2031”,
“CloneDetails”: “{“Clones”: [{“Name”: “cloridrato de ivabradina”, “Process Number”: “25351.866933/2021-46”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/2963585”}], “Clone”: “2. Clone Product Name: cloridrato de ivabradina\n Clone Process Number:25351.866933/2021-46\n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/2963585″}”,
“ActiveIngredient”: “CLORIDRATO DE IVABRADINA”,
“Packaging”: “Primária – Blister de alumínio e alumínionSecundária – Cartucho”,
“ManufacturingLocation”: “Fabricante: TORRENT PHARMACEUTICALS LTD.nCódigo único: A001089nEndereço: PLOT NO Z/104 TO106 DAHEJ SEZ PART-II, TAL – VAGRA, DIST – BHARUCH -392130 – ÍndianEtapa de Fabricação: Processo produtivo completo”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)”,
“PrescriptionRestriction”: “Venda sob Prescrição Médica”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “No Alert”,
“MatrixUpdateAlertDate”: “N/A”,
“RegularizationExpirationAlert”: “No Alert”
},
{
“ProductName”: “rivaroxabana”,
“RegularizationNumber”: “105250080”,
“RegularizationDate”: “16/09/2019”,
“CNPJ”: “33.078.528/0001-32”,
“CaseNumber”: “25351.201839/2017-95”,
“RegularizationDueDate”: “09/2029”,
“CloneDetails”: “{“Clones”: [{“Name”: “ACOG”, “Process Number”: “25351.230018/2017-31”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/1166654?cnpj=33078528000132&situacaoRegistro=V”}], “Clone Product Name”: “ACOG”, “Clone Process Number”: “25351.230018/2017-31”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/1166654?cnpj=33078528000132&situacaoRegistro=V”}”,
“ActiveIngredient”: “RIVAROXABANA”,
“Packaging”: “Primária – Blister de alumínio e alumínionSecundária – Cartucho”,
“ManufacturingLocation”: “Fabricante: TORRENT PHARMACEUTICALS LIMITEDnCódigo único: A000614nEndereço: AHMEDABAD – MEHSANA HIGHWAY – TALUKA-KADI, DISTRICT MEHSANA, INDRAD382721 GUJARAT – ÍndianEtapa de Fabricação: Processo produtivo completo”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)nPROTEGER DA UMIDADE”,
“PrescriptionRestriction”: “Venda sob Prescrição Médica”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “Annual Matrix update is due on 16/09/2025 which is within next 9 months. Please update it and also update the clones within 30 days of matrix update.”,
“MatrixUpdateAlertDate”: “16/09/2025”,
“RegularizationExpirationAlert”: “No Alert”
},
{
“ProductName”: “ARIPIPRAZOL”,
“RegularizationNumber”: “156490007”,
“RegularizationDate”: “01/02/2016”,
“CNPJ”: “05.399.786/0001-85”,
“CaseNumber”: “25351.643872/2012-43”,
“RegularizationDueDate”: “02/2026”,
“CloneDetails”: “”,
“ActiveIngredient”: “ARIPIPRAZOL”,
“Packaging”: “Primária – BLISTER DE ALUMINIO/ALUMINIOnSecundária – CARTUCHO CARTAO”,
“ManufacturingLocation”: “Fabricante: UNICHEM LABORATORIES LIMITEDnCódigo único: A000621nEndereço: C-31 &32 & D-10, INDUSTRIAL AREA, MEERUT ROAD, GHAZIABAD201003 – ÍndianEtapa de Fabricação:”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)”,
“PrescriptionRestriction”: “Venda sob prescrição médica com retenção de receita”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “Annual Matrix update is due on 01/02/2026 which is within next 9 months. Please update it and also update the clones within 30 days of matrix update.”,
“MatrixUpdateAlertDate”: “01/02/2026”,
“RegularizationExpirationAlert”: “Regularization will expire on 02/2026 which is within next 9 months. Please renew the regularization.”
},
{
“ProductName”: “telmisartana + hidroclorotiazida”,
“RegularizationNumber”: “155370096”,
“RegularizationDate”: “26/04/2021”,
“CNPJ”: “64.171.697/0001-46”,
“CaseNumber”: “25351.188508/2019-90”,
“RegularizationDueDate”: “04/2031”,
“CloneDetails”: “2. Clone Product Name: telmisartana + hidroclorotiazidan Clone Process Number:25351.443146/2024-72n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3780574n3. Clone Product Name: não registradon Clone Process Number:25351.007478/2025-78n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3789733n4. Clone Product Name: telmisartana + hidroclorotiazidan Clone Process Number:25351.530547/2023-81n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3646330n5. Clone Product Name: telmisartana + hidroclorotiazidan Clone Process Number:25351.140055/2024-88n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3709105n6. Clone Product Name: telmisartana + hidroclorotiazidan Clone Process Number:25351.255796/2022-09n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3297024n7. Clone Product Name: TELD HCTn Clone Process Number:25351.255786/2022-65n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3311890”,
“ActiveIngredient”: “TELMISARTANAnHIDROCLOROTIAZIDA”,
“Packaging”: “Primária – Blister de alumínio e alumínionSecundária – Cartucho”,
“ManufacturingLocation”: “Fabricante: INTAS PHARMACEUTICALS LIMITEDnCódigo único: A000704nEndereço: PLOT5 A14- PHARMEZ ,BUILDING: B, C AND G, NEAR VILLAGE MATODA, TAL-SANAND, CITY: MATODA, DIST: AHMEDABAD, GUJARAT STATE – ÍndianEtapa de Fabricação: Processo produtivo completo”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)nPROTEGER DA UMIDADE”,
“PrescriptionRestriction”: “Venda sob Prescrição Médica”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “Annual Matrix update is due on 26/04/2026 which is within next 9 months. Please update it and also update the clones within 30 days of matrix update.”,
“MatrixUpdateAlertDate”: “26/04/2026”,
“RegularizationExpirationAlert”: “No Alert”
},
{
“ProductName”: “OLMECOR HCT”,
“RegularizationNumber”: “105250114”,
“RegularizationDate”: “20/05/2024”,
“CNPJ”: “33.078.528/0001-32”,
“CaseNumber”: “25351.255787/2022-18”,
“RegularizationDueDate”: “05/2034”,
“CloneDetails”: “{“Clones”: [{“Name”: “olmesartana medoxomila + hidroclorotiazida”, “Process Number”: “25351.393719/2024-18”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/3801824?cnpj=33078528000132&situacaoRegistro=V”}], “Clone Product Name”: “olmesartana medoxomila + hidroclorotiazida”, “Clone Process Number”: “25351.393719/2024-18”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/3801824?cnpj=33078528000132&situacaoRegistro=V”}”,
“ActiveIngredient”: “OLMESARTANA MEDOXOMILAnHIDROCLOROTIAZIDA”,
“Packaging”: “Primária – Blister de alumínio e alumínionSecundária – Cartucho”,
“ManufacturingLocation”: “Fabricante: TORRENT PHARMACEUTICALS LTD.nCódigo único: A000615nEndereço: VILLAGE BHUD & MAKHNU MAJRA, TEHSIL: BADDI-173205- DISTT. SOLAN (H.P) – ÍndianEtapa de Fabricação: Processo produtivo completo”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)”,
“PrescriptionRestriction”: “Venda sob Prescrição Médica”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “No Alert”,
“MatrixUpdateAlertDate”: “N/A”,
“RegularizationExpirationAlert”: “No Alert”
}
][
{
“Certified Company”: “INTAS PHARMACEUTICALS LIMITED”,
“Code. Unique / Certified CNPJ”: “A000704”,
“Certified Company Address”: “PLOT 5 A 14- PHARMEZ ,BUILDING: B, C AND G, NEAR VILLAGE MATODA, TAL-SANAND, CITY: MATODA, DIST: AHMEDABAD, GUJARAT STATE”,
“Country”: “ÍNDIA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “70512 – MEDICAMENTOS – RENOVAÇÃO (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “29/10/2026”,
“Publication Date”: “29/10/2024”,
“Date of Resolution”: “24/10/2024”,
“Resolution”: “3.976”,
“Certificate Issued by”: “APROVAÇÃO TÁCITA ?”,
“N.DOU”: “209”,
“GMP certificate Expiration Alert”: “No alerts”
},
{
“Certified Company”: “UNICHEM LABORATORIES LIMITED”,
“Code. Unique / Certified CNPJ”: “A000621”,
“Certified Company Address”: “C-31 & 32 & D-10, INDUSTRIAL AREA, MEERUT ROAD, GHAZIABAD 201 003”,
“Country”: “ÍNDIA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “70512 – MEDICAMENTOS – RENOVAÇÃO (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “22/01/2026”,
“Publication Date”: “22/01/2024”,
“Date of Resolution”: “18/01/2024”,
“Resolution”: “211”,
“Certificate Issued by”: “APROVAÇÃO TÁCITA ?”,
“N.DOU”: “15”,
“GMP certificate Expiration Alert”: “Your GMP certificate is expiring on 22/01/2026 (in 9 months or less). Please renew it.”
},
{
“Certified Company”: “NATCO PHARMA LIMITED”,
“Code. Unique / Certified CNPJ”: “A001421”,
“Certified Company Address”: “PLOT NO. 89 E 90, JNPC, RAMKY PHARMA CITY, PARAWADA VISAKHAPATNAM-531019,ANDHRA PRADESH”,
“Country”: “ÍNDIA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “769 – MEDICAMENTOS – (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “04/11/2026”,
“Publication Date”: “04/11/2024”,
“Date of Resolution”: “31/10/2024”,
“Resolution”: “4.073”,
“Certificate Issued by”: “ANÁLISE DE RISCO ?”,
“N.DOU”: “213”,
“GMP certificate Expiration Alert”: “No alerts”
},
{
“Certified Company”: “ATHENA DRUG DELIVERY SOLUTIONS PVT. LTD.”,
“Code. Unique / Certified CNPJ”: “A001229”,
“Certified Company Address”: “PLOT NO. A-1 TO A-5, MIDC, CHEMICAL ZONE, AMBERNATH (W), THANE 421501, MAHARASHTRA STATE”,
“Country”: “ÍNDIA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “70512 – MEDICAMENTOS – RENOVAÇÃO (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “21/10/2026”,
“Publication Date”: “21/10/2024”,
“Date of Resolution”: “17/10/2024”,
“Resolution”: “3.860”,
“Certificate Issued by”: “APROVAÇÃO TÁCITA ?”,
“N.DOU”: “204”,
“GMP certificate Expiration Alert”: “No alerts”
},
{
“Certified Company”: “LABORATORIOS LICONSA S.A.”,
“Code. Unique / Certified CNPJ”: “A000705”,
“Certified Company Address”: “AVDA. MIRALCAMPO, 7, POL. IND. MIRALCAMPO, AZUQUECA DE HENARES 19200 (GUADALAJARA)”,
“Country”: “ESPANHA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “70512 – MEDICAMENTOS – RENOVAÇÃO (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “22/04/2027”,
“Publication Date”: “22/04/2025”,
“Date of Resolution”: “16/04/2025”,
“Resolution”: “1.503”,
“Certificate Issued by”: “RENOVAÇÃO AUTOMÁTICA ?”,
“N.DOU”: “75”,
“GMP certificate Expiration Alert”: “No alerts”
}
]
{
“ProductName”: “IVAHART”,
“RegularizationNumber”: “105250090”,
“RegularizationDate”: “07/06/2021”,
“CNPJ”: “33.078.528/0001-32”,
“CaseNumber”: “25351.679486/2018-91”,
“RegularizationDueDate”: “06/2031”,
“CloneDetails”: “{“Clones”: [{“Name”: “cloridrato de ivabradina”, “Process Number”: “25351.866933/2021-46”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/2963585”}], “Clone”: “2. Clone Product Name: cloridrato de ivabradina\n Clone Process Number:25351.866933/2021-46\n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/2963585″}”,
“ActiveIngredient”: “CLORIDRATO DE IVABRADINA”,
“Packaging”: “Primária – Blister de alumínio e alumínionSecundária – Cartucho”,
“ManufacturingLocation”: “Fabricante: TORRENT PHARMACEUTICALS LTD.nCódigo único: A001089nEndereço: PLOT NO Z/104 TO106 DAHEJ SEZ PART-II, TAL – VAGRA, DIST – BHARUCH -392130 – ÍndianEtapa de Fabricação: Processo produtivo completo”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)”,
“PrescriptionRestriction”: “Venda sob Prescrição Médica”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “No Alert”,
“MatrixUpdateAlertDate”: “N/A”,
“RegularizationExpirationAlert”: “No Alert”
},
{
“ProductName”: “rivaroxabana”,
“RegularizationNumber”: “105250080”,
“RegularizationDate”: “16/09/2019”,
“CNPJ”: “33.078.528/0001-32”,
“CaseNumber”: “25351.201839/2017-95”,
“RegularizationDueDate”: “09/2029”,
“CloneDetails”: “{“Clones”: [{“Name”: “ACOG”, “Process Number”: “25351.230018/2017-31”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/1166654?cnpj=33078528000132&situacaoRegistro=V”}], “Clone Product Name”: “ACOG”, “Clone Process Number”: “25351.230018/2017-31”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/1166654?cnpj=33078528000132&situacaoRegistro=V”}”,
“ActiveIngredient”: “RIVAROXABANA”,
“Packaging”: “Primária – Blister de alumínio e alumínionSecundária – Cartucho”,
“ManufacturingLocation”: “Fabricante: TORRENT PHARMACEUTICALS LIMITEDnCódigo único: A000614nEndereço: AHMEDABAD – MEHSANA HIGHWAY – TALUKA-KADI, DISTRICT MEHSANA, INDRAD382721 GUJARAT – ÍndianEtapa de Fabricação: Processo produtivo completo”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)nPROTEGER DA UMIDADE”,
“PrescriptionRestriction”: “Venda sob Prescrição Médica”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “Annual Matrix update is due on 16/09/2025 which is within next 9 months. Please update it and also update the clones within 30 days of matrix update.”,
“MatrixUpdateAlertDate”: “16/09/2025”,
“RegularizationExpirationAlert”: “No Alert”
},
{
“ProductName”: “ARIPIPRAZOL”,
“RegularizationNumber”: “156490007”,
“RegularizationDate”: “01/02/2016”,
“CNPJ”: “05.399.786/0001-85”,
“CaseNumber”: “25351.643872/2012-43”,
“RegularizationDueDate”: “02/2026”,
“CloneDetails”: “”,
“ActiveIngredient”: “ARIPIPRAZOL”,
“Packaging”: “Primária – BLISTER DE ALUMINIO/ALUMINIOnSecundária – CARTUCHO CARTAO”,
“ManufacturingLocation”: “Fabricante: UNICHEM LABORATORIES LIMITEDnCódigo único: A000621nEndereço: C-31 &32 & D-10, INDUSTRIAL AREA, MEERUT ROAD, GHAZIABAD201003 – ÍndianEtapa de Fabricação:”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)”,
“PrescriptionRestriction”: “Venda sob prescrição médica com retenção de receita”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “Annual Matrix update is due on 01/02/2026 which is within next 9 months. Please update it and also update the clones within 30 days of matrix update.”,
“MatrixUpdateAlertDate”: “01/02/2026”,
“RegularizationExpirationAlert”: “Regularization will expire on 02/2026 which is within next 9 months. Please renew the regularization.”
},
{
“ProductName”: “telmisartana + hidroclorotiazida”,
“RegularizationNumber”: “155370096”,
“RegularizationDate”: “26/04/2021”,
“CNPJ”: “64.171.697/0001-46”,
“CaseNumber”: “25351.188508/2019-90”,
“RegularizationDueDate”: “04/2031”,
“CloneDetails”: “2. Clone Product Name: telmisartana + hidroclorotiazidan Clone Process Number:25351.443146/2024-72n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3780574n3. Clone Product Name: não registradon Clone Process Number:25351.007478/2025-78n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3789733n4. Clone Product Name: telmisartana + hidroclorotiazidan Clone Process Number:25351.530547/2023-81n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3646330n5. Clone Product Name: telmisartana + hidroclorotiazidan Clone Process Number:25351.140055/2024-88n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3709105n6. Clone Product Name: telmisartana + hidroclorotiazidan Clone Process Number:25351.255796/2022-09n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3297024n7. Clone Product Name: TELD HCTn Clone Process Number:25351.255786/2022-65n Clone URL: https://consultas.anvisa.gov.br/#/medicamentos/3311890”,
“ActiveIngredient”: “TELMISARTANAnHIDROCLOROTIAZIDA”,
“Packaging”: “Primária – Blister de alumínio e alumínionSecundária – Cartucho”,
“ManufacturingLocation”: “Fabricante: INTAS PHARMACEUTICALS LIMITEDnCódigo único: A000704nEndereço: PLOT5 A14- PHARMEZ ,BUILDING: B, C AND G, NEAR VILLAGE MATODA, TAL-SANAND, CITY: MATODA, DIST: AHMEDABAD, GUJARAT STATE – ÍndianEtapa de Fabricação: Processo produtivo completo”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)nPROTEGER DA UMIDADE”,
“PrescriptionRestriction”: “Venda sob Prescrição Médica”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “Annual Matrix update is due on 26/04/2026 which is within next 9 months. Please update it and also update the clones within 30 days of matrix update.”,
“MatrixUpdateAlertDate”: “26/04/2026”,
“RegularizationExpirationAlert”: “No Alert”
},
{
“ProductName”: “OLMECOR HCT”,
“RegularizationNumber”: “105250114”,
“RegularizationDate”: “20/05/2024”,
“CNPJ”: “33.078.528/0001-32”,
“CaseNumber”: “25351.255787/2022-18”,
“RegularizationDueDate”: “05/2034”,
“CloneDetails”: “{“Clones”: [{“Name”: “olmesartana medoxomila + hidroclorotiazida”, “Process Number”: “25351.393719/2024-18”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/3801824?cnpj=33078528000132&situacaoRegistro=V”}], “Clone Product Name”: “olmesartana medoxomila + hidroclorotiazida”, “Clone Process Number”: “25351.393719/2024-18”, “Clone URL”: “https://consultas.anvisa.gov.br/#/medicamentos/3801824?cnpj=33078528000132&situacaoRegistro=V”}”,
“ActiveIngredient”: “OLMESARTANA MEDOXOMILAnHIDROCLOROTIAZIDA”,
“Packaging”: “Primária – Blister de alumínio e alumínionSecundária – Cartucho”,
“ManufacturingLocation”: “Fabricante: TORRENT PHARMACEUTICALS LTD.nCódigo único: A000615nEndereço: VILLAGE BHUD & MAKHNU MAJRA, TEHSIL: BADDI-173205- DISTT. SOLAN (H.P) – ÍndianEtapa de Fabricação: Processo produtivo completo”,
“RouteofAdministration”: “ORAL”,
“Conservation”: “CONSERVAR EM TEMPERATURA AMBIENTE ( AMBIENTE COM TEMPERATURA ENTRE15 E30ºC)”,
“PrescriptionRestriction”: “Venda sob Prescrição Médica”,
“Restrictionofuse”: “Adulto”,
“MatrixUpdateAlert”: “No Alert”,
“MatrixUpdateAlertDate”: “N/A”,
“RegularizationExpirationAlert”: “No Alert”
}
][
{
“Certified Company”: “INTAS PHARMACEUTICALS LIMITED”,
“Code. Unique / Certified CNPJ”: “A000704”,
“Certified Company Address”: “PLOT 5 A 14- PHARMEZ ,BUILDING: B, C AND G, NEAR VILLAGE MATODA, TAL-SANAND, CITY: MATODA, DIST: AHMEDABAD, GUJARAT STATE”,
“Country”: “ÍNDIA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “70512 – MEDICAMENTOS – RENOVAÇÃO (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “29/10/2026”,
“Publication Date”: “29/10/2024”,
“Date of Resolution”: “24/10/2024”,
“Resolution”: “3.976”,
“Certificate Issued by”: “APROVAÇÃO TÁCITA ?”,
“N.DOU”: “209”,
“GMP certificate Expiration Alert”: “No alerts”
},
{
“Certified Company”: “UNICHEM LABORATORIES LIMITED”,
“Code. Unique / Certified CNPJ”: “A000621”,
“Certified Company Address”: “C-31 & 32 & D-10, INDUSTRIAL AREA, MEERUT ROAD, GHAZIABAD 201 003”,
“Country”: “ÍNDIA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “70512 – MEDICAMENTOS – RENOVAÇÃO (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “22/01/2026”,
“Publication Date”: “22/01/2024”,
“Date of Resolution”: “18/01/2024”,
“Resolution”: “211”,
“Certificate Issued by”: “APROVAÇÃO TÁCITA ?”,
“N.DOU”: “15”,
“GMP certificate Expiration Alert”: “Your GMP certificate is expiring on 22/01/2026 (in 9 months or less). Please renew it.”
},
{
“Certified Company”: “NATCO PHARMA LIMITED”,
“Code. Unique / Certified CNPJ”: “A001421”,
“Certified Company Address”: “PLOT NO. 89 E 90, JNPC, RAMKY PHARMA CITY, PARAWADA VISAKHAPATNAM-531019,ANDHRA PRADESH”,
“Country”: “ÍNDIA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “769 – MEDICAMENTOS – (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “04/11/2026”,
“Publication Date”: “04/11/2024”,
“Date of Resolution”: “31/10/2024”,
“Resolution”: “4.073”,
“Certificate Issued by”: “ANÁLISE DE RISCO ?”,
“N.DOU”: “213”,
“GMP certificate Expiration Alert”: “No alerts”
},
{
“Certified Company”: “ATHENA DRUG DELIVERY SOLUTIONS PVT. LTD.”,
“Code. Unique / Certified CNPJ”: “A001229”,
“Certified Company Address”: “PLOT NO. A-1 TO A-5, MIDC, CHEMICAL ZONE, AMBERNATH (W), THANE 421501, MAHARASHTRA STATE”,
“Country”: “ÍNDIA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “70512 – MEDICAMENTOS – RENOVAÇÃO (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “21/10/2026”,
“Publication Date”: “21/10/2024”,
“Date of Resolution”: “17/10/2024”,
“Resolution”: “3.860”,
“Certificate Issued by”: “APROVAÇÃO TÁCITA ?”,
“N.DOU”: “204”,
“GMP certificate Expiration Alert”: “No alerts”
},
{
“Certified Company”: “LABORATORIOS LICONSA S.A.”,
“Code. Unique / Certified CNPJ”: “A000705”,
“Certified Company Address”: “AVDA. MIRALCAMPO, 7, POL. IND. MIRALCAMPO, AZUQUECA DE HENARES 19200 (GUADALAJARA)”,
“Country”: “ESPANHA”,
“Requesting Company”: “TORRENT DO BRASIL LTDA”,
“CNPJ (Requesting Company)”: “33.078.528/0001-32”,
“Requesting Company Address”: “AVENIDA TAMBORÉ, N° 1180, MÓDULOS A3, A4, A5 E A6.”,
“City / State”: “BARUERI / SP”,
“Subject”: “70512 – MEDICAMENTOS – RENOVAÇÃO (Certificação de BPF) de INDÚSTRIA INTERNACIONAL de SÓLIDOS NÃO ESTÉREIS, exceto MERCOSUL”,
“Certificate Type”: “CBPF”,
“Expiration Date”: “22/04/2027”,
“Publication Date”: “22/04/2025”,
“Date of Resolution”: “16/04/2025”,
“Resolution”: “1.503”,
“Certificate Issued by”: “RENOVAÇÃO AUTOMÁTICA ?”,
“N.DOU”: “75”,
“GMP certificate Expiration Alert”: “No alerts”
}
]